#2987
68Ga-DOTATOC PET/CT as Tool for Diagnosis and Decision-Making Process of Neuroendocrine Tumors
Introduction:
Primary tumors in some patients with metastatic neuroendocrine tumors (NET) cannot be found by conventional imaging as CT, MRI and scintigraphy. 68Ga-DOTATOC PET/CT (68Ga-PET) appears to have superior sensitivity, specifity, and better resolution than 99mTC-octreotide SPECT/TC (SSTR scintigraphy) and can improve decision-making process, however its cost is higher, and its availability is limited.
Conference:
17th Annual ENETSConcerence (2020)
Presenting Author:
Authors:
Peiró I,
Vercher-Conejero J,
Suils-Ramón J,
Hernández L,
Teulé A,
Keywords:
68Ga-DOTATOC PET/CT,
metastatic neuroendocrine tumors,
#2903
Bone Metastases (BM) in Neuroendocrine Tumors (NET): Imaging Characteristics and Clinical Implications. A Single-Institution Experience
Introduction:
The incidence of BM in NET is underestimated and there is no consensus on clinical features, diagnostic techniques, and treatment options.
Conference:
17th Annual ENETSConcerence (2020)
Presenting Author:
Smiroldo V
Authors:
Smiroldo V,
Lania A,
Pedicini V,
Pepe G,
Zerbi A,
Keywords:
bone metastases,
skeletal related event,
survival,
bisphosphonates,
68Ga-PET,
18FDG-PET,
CT scan,
#2237
99mTc-Colloid Scintigraphy in the Differential Diagnosis of Pancreatic NET
Introduction:
An accessory spleen (AS), a benign and congenital condition, is characterized by a small nodule of splenic tissue found outside of the spleen, which can mimic a pancreatic neoplasm (p-NET). 68Ga-PET/CT is used to study lesions suspected for NET, but the radioactive tracer binds also the reticuloendothelial cells, resulting in false positives in case of AS.
Conference:
15th Annual ENETSConcerence (2018)
Presenting Author:
Chiloiro S
Authors:
Chiloiro S,
Mirra F,
Donfrancesco F,
Bianchi A,
Bima C,
Keywords:
99mTc-colloid scintigraphy,
